The answer is yes, as they work through different pathways and complement each other well
If the provider determines that GLP-1 medication is appropriate, they consider which medication and starting dose is safest for you, what monitoring is needed, and what follow-up schedule is appropriate
Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S
This is why researchers have been so interested in combining the two approaches, and why cagrilintide on its own produces appetite suppression through mechanisms that don't fully overlap with semaglutide or tirzepatide
Mol Aspects Med 30: 4259, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar] 44.Stipanuk MH, Dominy JE, Jr, Lee JI, Coloso RM: Mammalian cysteine metabolism: New insights into regulation of cysteine metabolism